March 1, 2011Postgraduate Medicine
Potential Role of Renin-Angiotensin System Blockade for Preventing Myocardial Ischemia/Reperfusion Injury and Remodeling after Myocardial Infarction
Population
Experimental animal models and clinical patients with myocardial infarction
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports RAS inhibition post-MI based on reviewed data; leaves open exact cardioprotective mechanisms for further study.
Key Points
- To summarize evidence regarding the activation of the renin-angiotensin system during myocardial infarction and evaluate the therapeutic mechanisms of its blockade.
- Synthesized findings from experimental animal studies and clinical trials investigating the activation of renin-angiotensin system components during acute ischemia.
- Reviewed therapeutic interventions involving renin inhibitors, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in myocardial infarction.
- Myocardial ischemia induces rapid upregulation of angiotensinogen, renin, angiotensin-converting enzyme, and angiotensin receptors during acute injury and subsequent remodeling.
- Pharmacological blockade of the renin-angiotensin system consistently attenuates pathological injury and adverse structural remodeling across experimental and clinical studies.
Structured PICO
P
Population
Experimental animal models and clinical patients with myocardial infarction
I
Intervention
Renin-angiotensin system (RAS) blockade (renin inhibitors, ACE inhibitors, and angiotensin receptor blockers)
O
Outcome
Prevention of myocardial ischemia/reperfusion injury and postinfarction remodeling
This review highlights the beneficial effects and explores the potential mechanisms of RAS blockade in preventing myocardial ischemia/reperfusion injury and adverse remodeling following myocardial infarction.
Cite This Study
Dai et al. (2011) studied this question.